Plunkett Research Online: Pharmacyclics LLC

PHARMACYCLICS LLC (Subsidiary) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Pharmacyclics, LLC is a fully-integrated biopharmaceutical company focused on developing and commercializing novel cancer and immune-mediated disease treatment. Its first commercial product, Imbruvica (ibrutinib), is a first-in-class, oral, once-daily, single-agent therapy for difficult-to-treat bl.....


PHARMACYCLICS LLC

Ticker: Subsidiary
Exchange:
Parent Company:
Employees:
Fiscal Year Ends in

Phone: 408 774-0330
Fax: 408 774-0340
Address: 995 E. Arques Ave.
Sunnyvale, CA 94085 United States

Types Of Business
Industry Ranks

Industry NAICS code:
Parent Company: AbbVie Inc

ContactsDescription

Jesse McGreivyChief Medical Officer
Stefan GeldmeyerDir.-Finance & Infrastructure
See More
Pharmacyclics, LLC is a fully-integrated biopharmaceutical company focused on developing and commercializing novel cancer and immune-mediated disease treatment. Its first commercial product, Imbruvica (ibrutinib), is a first-in-class, oral, once-daily, single-agent therapy for difficult-to-treat bl.....See More See More

$USD, In whole numbers 2017201620152014201320122011
Sales
Profits
Brands, Divisions and AffiliatesTop Salaries
Salary
Bonus
Other ThoughtsCorporate Culture